🇺🇸 FDA
Patent

US 6413773

Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation

expired A61KA61K31/366A61K31/5377

Quick answer

US patent 6413773 (Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation) held by The Regents of the University of California expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/366, A61K31/5377